MATCHING-ADJUSTED INDIRECT COMPARISON OF UPADACITINIB VERSUS USTEKINUMAB ON ENDOSCOPIC OUTCOMES AMONG PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
Christopher Ma 1
Marla C. Dubinsky 2
Jordan Axelrad 3
Samuel Anyanwu 4
Jacinda Tran 4, 5
Namita Joshi
Jenny Griffith
1 University of Caglary, Calgary, Canada
2 Icahn School of Medicine, Mount Sinai, New York City, United States
3 NYU Grossman School of Medicine, New York, United States
4 AbbVie, Inc, North Chicago, United States
5 University of Washington, Seattle, United States
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]